The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Last week, Eli Lilly, the maker of Zepbound, also cut prices for ... People using these GLP-1 meds start with smaller doses ...

Zepbound has now been added to that list ... The company is also running a deal to get the higher doses, 7.5 mg and 10 mg, also at $499, according to the LillyDirect website at press time.

Makers of Wegovy & Zepbound Cut Prices for Those Without ... People using these GLP-1 meds start with smaller doses and gradually increase to higher amounts over time. The price cuts come as ...

Last summer, Lilly started selling vials of the 2.5 mg and 5 mg doses of Zepbound online through its ... or if they’re going to prioritize high prices and short-term profits over widespread ...

a common starting dosage, and 5 milligrams. The charge is $349 or $499 a month, respectively. With its new Zepbound Self Pay Journey Program, the company also introduced higher dosages of Zepbound ...